Navigation Links
ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
Date:1/8/2009

affected by risks related to competition from other biotechnology and pharmaceutical companies, its effectiveness at managing its financial resources, its ability to enter into collaborations around its product candidates, its ability to successfully develop and market products, difficulties or delays in its preclinical studies or clinical trials, difficulties or delays in manufacturing its clinical trials materials, the scope and validity of patent protection for its product candidates, regulatory developments involving its product candidates and its ability to obtain additional funding to support its operations. Risk factors that may cause actual results to differ are more fully discussed in Anadys' SEC filings, including Anadys' Form 10-K for the year ended December 31, 2007 and Anadys' Form 10-Q for the quarter ended September 30, 2008. All forward-looking statements are qualified in their entirety by this cautionary statement. Anadys is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.


'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
6. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
7. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
8. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
9. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
10. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
11. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2015)... 2015 A new study shows how ... reduce asthma-related illness. The Cincinnati Children,s ... neighborhoods with high rates of asthma-related emergency-room use ... to asthma rescue medications. Asthma-related illness ... or with limited access to medical care. Previous ...
(Date:5/1/2015)... CHAPEL HILL, N.C. , May 1, 2015 /PRNewswire/ ... from payers for its high price but manufacturer Gilead ... programs, strategic worldwide pricing, and effective public relations campaigns. ... and promise of less severe side effects propelled the ... quarter of 2014, the therapy,s first quarter on the ...
(Date:5/1/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/vzcw2v/americas_clinical ) has announced the ... Product, by End-Users - Forecast to 2019" report to ... is estimated to grow at a CAGR of 5.2% from ... Canada , Mexico , ... in this report. The Americas is the largest ...
Breaking Medicine Technology:New Study Suggests Prominent Role for Pharmacies In Reducing Asthma-related Illness 2New Study Suggests Prominent Role for Pharmacies In Reducing Asthma-related Illness 3New Study Examines Success Lessons of Sovaldi's and Harvoni's Blockbuster Launches 2Americas Clinical Chemistry Analyzer (Semi-Automated Clinical Chemistry and Fully-Automated Clinical Chemistry) Market - Forecast to 2019 2
... VEDRA BEACH, Fla., Sept. 27, 2011 Nuance Health ... that was conducted on their innovative product, Swype Cold ... season.   The clinical study, conducted on ... colds, evaluated the effectiveness, tolerability, and willingness of participants ...
... a result of the flagging economy, Americans are making ... according to Consumer Reports, annual prescription drug poll.  Forty-eight ... told pollsters they,d cut health-care costs, for example, by ... tests, or ordering cheaper drugs from outside of the ...
Cached Medicine Technology:Swype Cold & Flu Shield Significantly Reduces Occurrence of Colds in Clinical Study 2Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 2Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 3Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 4Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 5
(Date:5/4/2015)... Elisabeth Rosenthal’s article* on “balance billing” ... the healthcare fraternity as well as patients about ... of balance billing. In definition, balance billing is ... patient for the difference between what the patient's ... provider chooses to charge. Rosenthal’s article talks about ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 For partners ... brand new lubricant -- Astroglide TTC™ (Trying to ... motility and alter pH levels, Astroglide TTC™ is specially ... , According to the Centers for Disease Control, an ... trouble getting pregnant or sustaining a pregnancy, and over ...
(Date:5/4/2015)... Dallas, Texas (PRWEB) May 04, 2015 ... did about our mothers. He said, “My mother was the ... Mother’s Day, wrap her in lovely, feminine prints and ... is. , Look no further than the Eloise Robe to ... feminine feel with its cap sleeve and tapered waist. It ...
(Date:5/3/2015)... Barbara Crone has joined Women’s Excellence in ... of the men, women and families who seek her care, initially ... for families in the home. , “When the ... if I could complete their care with the delivery of their ... mentor Nurse Midwife, I knew it was time for me to ...
(Date:5/3/2015)... (PRWEB) May 03, 2015 Indiana Fiber ... Provider announces Bank Computer Services, Inc (BCS) has selected ... BCS’ President states, “The technology, service, and working relationship ... like is the local feel you get with IFN. ... managed company; IFN makes local decisions and operates as ...
Breaking Medicine News(10 mins):Health News:Out of Network Balance Billing Without Being Viewed as Fraud 2Health News:Out of Network Balance Billing Without Being Viewed as Fraud 3Health News:Astroglide Announces the Birth of Its New Baby: Astroglide TTC 2Health News:Astroglide Announces the Birth of Its New Baby: Astroglide TTC 3Health News:Feminine Classics for Mother's Day Gifts from Peacock Alley 2Health News:Women's Excellence In Midwifery Welcomes Barbara Crone 2Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 3
... and repair some of the natural telomere DNA shortening that ... update and release of its latest science-based telomere ... To understand what and how Astral Fruit works we can ... dysfunction and DNA damage represent biomarkers of human aging and ...
... Gene reprogramming can occur in just 3 days time , , ... even a short period of time can cause some genes ... developing cancer and other diseases, say Italian researchers. , ... exposed to high levels of airborne particulates at a foundry ...
... SAN DIEGOA new study using advanced cardiac imaging technology ... following competition are temporary, and do not result in ... researchers at the University of Manitoba, marked the first ... a post-marathon setting., The research will be presented on ...
... phone calling may help physicians solve a perennial problem: ... conditions., Researchers at the Kaiser Permanente Center for Health ... designed to encourage patients with asthma to fill or ... The research will be presented on May 17 at ...
... De La Cruz is turning to the power of social media giant Twitter ... the life of her 27-year old brother Eric, in dire need of a ... ... part to Twitter, a one-woman fight to get her severely ill brother a ...
... is pleased and excited to announce the introduction of Perma Facial ... the face. , ... Austin, Texas (PRWEB) -- Widner ... the introduction of Perma Facial ImplantTM, a safe definitive solution for ...
Cached Medicine News:Health News:RevGenetics Releases Its New Science-Based Telomere Health Supplement Formulation for DNA and Chromosome Health 2Health News:RevGenetics Releases Its New Science-Based Telomere Health Supplement Formulation for DNA and Chromosome Health 3Health News:RevGenetics Releases Its New Science-Based Telomere Health Supplement Formulation for DNA and Chromosome Health 4Health News:Short-Term Air Pollution Exposure May Damage DNA 2Health News:Study sees transient heart dysfunction in some long-distance runners 2Health News:Increasing ICS compliance: The voice may be recorded, but the results are real 2Health News:Increasing ICS compliance: The voice may be recorded, but the results are real 3Health News:Twitter Boosts CNN Reporter's Fight to Save Her Brother's Life 2Health News:Twitter Boosts CNN Reporter's Fight to Save Her Brother's Life 3Health News:Widner Oral Surgery is the First Oral Surgery Practice in Austin to Offer Perma Facial ImplantsTM 2
Fine .12mm Tip With 5mm Platform; In Titanium....
Angled tip, 0.3mm triangular grasping tips; In Titanium....
... addition to any Trial ... Trial Frame provides a ... controls for quick, easy ... high-quality materials, and precision ...
... The Ultramatic Rx Master is ... years of reliable service and ... that measurably improve procedures. It ... need and want most, including ...
Medicine Products: